FSSNX | PRVIX | FSSNX / PRVIX | |
Total Expense Ratio | 0.03 | 0.66 | 4% |
Annual Report Gross Expense Ratio | 0.03 | 0.66 | 4% |
Fund Existence | 14 years | 10 years | - |
Gain YTD | 3.468 | 1.406 | 247% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 500000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 25.9B | 9.87B | 262% |
Annual Yield % from dividends | 0.90 | 1.00 | 91% |
Returns for 1 year | 8.73 | -1.80 | -485% |
Returns for 3 years | 18.75 | -4.73 | -396% |
Returns for 5 years | 51.48 | 24.23 | 212% |
Returns for 10 years | 85.72 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FBT | 174.32 | 2.37 | +1.38% |
First Trust NYSE Arca Biotech ETF | |||
OCTT | 41.41 | -0.06 | -0.14% |
AllianzIM US Large Cap Buffer10 Oct ETF | |||
RND | 28.10 | -0.06 | -0.20% |
First Trust Bloomberg R&D Leaders ETF | |||
GGLS | 10.73 | -0.05 | -0.42% |
Direxion Daily GOOGL Bear 1X ETF | |||
RFV | 123.76 | -1.19 | -0.95% |
Invesco S&P MidCap 400® Pure Value ETF |